The challenge
A Japanese diagnostics company knew they wanted to enter Europe — but treated it as a single market. They had no framework for deciding which countries to prioritise, in what order, or how to position differently across regulatory and healthcare cultures that varied dramatically from country to country. Without a clear sequence, they risked spreading resources across the wrong markets at the wrong moment.
The approach
DSA conducted a structured prioritisation across six European markets — assessing regulatory complexity, reimbursement dynamics, competitive landscape, and adoption readiness for this specific innovation. We built distinct positioning frameworks for each priority market, grounded in the clinical and institutional logic of each system. The output wasn't a report to file — it was a decision-ready strategy the whole team could align around and act on immediately.
The outcome
The company entered Europe with a sequenced market strategy and differentiated positioning for each priority country. What had felt like an overwhelming landscape became a clear order of operations. The CCO reflected that the clarity DSA provided saved them years of costly trial and error.
Europe is not one market. DSA helped us understand which countries to prioritise first and how to position differently in each — that clarity alone saved us years of trial and error.
Hiroshi Y.
The challenge
A Japanese diagnostics company knew they wanted to enter Europe — but treated it as a single market. They had no framework for deciding which countries to prioritise, in what order, or how to position differently across regulatory and healthcare cultures that varied dramatically from country to country. Without a clear sequence, they risked spreading resources across the wrong markets at the wrong moment.
The approach
DSA conducted a structured prioritisation across six European markets — assessing regulatory complexity, reimbursement dynamics, competitive landscape, and adoption readiness for this specific innovation. We built distinct positioning frameworks for each priority market, grounded in the clinical and institutional logic of each system. The output wasn't a report to file — it was a decision-ready strategy the whole team could align around and act on immediately.
The outcome
The company entered Europe with a sequenced market strategy and differentiated positioning for each priority country. What had felt like an overwhelming landscape became a clear order of operations. The CCO reflected that the clarity DSA provided saved them years of costly trial and error.
Europe is not one market. DSA helped us understand which countries to prioritise first and how to position differently in each — that clarity alone saved us years of trial and error.
Hiroshi Y.